Literature DB >> 30852912

Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model.

Selcan Ekicier Acar1, M Sinan Sarıcaoğlu2, Aysel Çolak3, Zeynep Aktaş4, Aylin Sepici Dinçel5.   

Abstract

PURPOSE: We aimed to create mechanic optic nerve injury model in rats and investigate the neuroprotective effects of topical Coenzyme Q10 + Vitamin E (CoQ + Vit.E) molecules on retinal ganglion cells.
METHODS: Mechanic optic nerve injury model was created in the right eyes of rats (n = 12). Rats were divided into two groups: glaucoma model with sham treatment and topical CoQ + Vit.E treatment. Treatment was applied for 4 weeks. Glial fibrillary acidic protein, Brn-3a antibody, and anti-Iba1 were examined by immunohistochemistry. Glial fibrillary acidic protein, Bax, Bcl-xL, and Tfam protein expression were measured by Western blot analysis.
RESULTS: The number of Brn-3a-positive retinal ganglion cell was 15.0 ± 1.0 (min: 14, max: 16) in sham treatment group and 22.2 ± 4.8 (min: 18, max: 29) in topical CoQ10 + Vit.E treatment group. The protection of Brn-3a in CoQ10 + Vit.E was statistically significant (p < 0.05). Glial fibrillary acidic protein-positive astroglial counts were recorded as 11.7 ± 2.1 (min: 10, max: 14) in sham treatment and 2.5 ± 1.5 (min: 1, max: 4) in topical CoQ10 + Vit.E treatment group (p < 0.05). Topical CoQ10 + Vit.E treatment also decreased Iba1 expression in the retina of mechanic optic nerve injury groups. CoQ10 + Vit.E treatment prevented apoptotic cell death by increasing Bcl-xL protein expression. Also, CoQ10 + Vit.E preserved Tfam protein expression in the retina.
CONCLUSION: This study has shown that in glaucoma treatment the neuron protecting effect of topical CoQ10 + Vit.E molecules can be valuable.

Entities:  

Keywords:  Rat glaucoma model; coenzyme Q10 + vitamin E; neuroprotection; retinal ganglion cell number

Mesh:

Substances:

Year:  2019        PMID: 30852912     DOI: 10.1177/1120672119833271

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  6 in total

1.  Effects of Citicoline, Homotaurine, and Vitamin E on Contrast Sensitivity and Visual-Related Quality of Life in Patients with Primary Open-Angle Glaucoma: A Preliminary Study.

Authors:  Pier Franco Marino; Gemma Caterina Maria Rossi; Giuseppe Campagna; Decio Capobianco; Ciro Costagliola
Journal:  Molecules       Date:  2020-11-29       Impact factor: 4.411

2.  Investigation of coenzyme Q10 status, serum amyloid-β, and tau protein in patients with dementia.

Authors:  Po-Sheng Chang; Hsi-Hsien Chou; Te-Jen Lai; Chi-Hua Yen; Ji-Cyun Pan; Ping-Ting Lin
Journal:  Front Aging Neurosci       Date:  2022-07-25       Impact factor: 5.702

Review 3.  New strategies for neuro protection in glaucoma.

Authors:  Yang Xuejiao; Yan Junwei
Journal:  Front Cell Dev Biol       Date:  2022-09-15

Review 4.  Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications.

Authors:  Lin Fu; Sum Sum Kwok; Yau Kei Chan; Jimmy Shiu Ming Lai; Weihua Pan; Li Nie; Kendrick Co Shih
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

Review 5.  Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma.

Authors:  Annagrazia Adornetto; Laura Rombolà; Luigi Antonio Morrone; Carlo Nucci; Maria Tiziana Corasaniti; Giacinto Bagetta; Rossella Russo
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

Review 6.  Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update.

Authors:  Ru Hui Sim; Srinivasa Rao Sirasanagandla; Srijit Das; Seong Lin Teoh
Journal:  Nutrients       Date:  2022-01-26       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.